Logo image of ALCOX.PA

NICOX SA (ALCOX.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALCOX - FR0013018124 - Common Stock

0.2965 EUR
-0.01 (-2.47%)
Last: 12/8/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALCOX. ALCOX was compared to 83 industry peers in the Biotechnology industry. ALCOX may be in some trouble as it scores bad on both profitability and health. ALCOX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALCOX had negative earnings in the past year.
ALCOX had negative earnings in each of the past 5 years.
In the past 5 years ALCOX always reported negative operating cash flow.
ALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

ALCOX has a worse Return On Assets (-179.67%) than 90.36% of its industry peers.
Industry RankSector Rank
ROA -179.67%
ROE N/A
ROIC N/A
ROA(3y)-53.69%
ROA(5y)-42.4%
ROE(3y)-266.03%
ROE(5y)-174.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALCOX.PA Yearly ROA, ROE, ROICALCOX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

ALCOX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCOX.PA Yearly Profit, Operating, Gross MarginsALCOX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for ALCOX has been increased compared to 1 year ago.
Compared to 5 years ago, ALCOX has more shares outstanding
The debt/assets ratio for ALCOX is higher compared to a year ago.
ALCOX.PA Yearly Shares OutstandingALCOX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALCOX.PA Yearly Total Debt VS Total AssetsALCOX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -57.64, we must say that ALCOX is in the distress zone and has some risk of bankruptcy.
ALCOX's Altman-Z score of -57.64 is on the low side compared to the rest of the industry. ALCOX is outperformed by 87.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.64
ROIC/WACCN/A
WACCN/A
ALCOX.PA Yearly LT Debt VS Equity VS FCFALCOX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 11.02 indicates that ALCOX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.02, ALCOX belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
ALCOX has a Quick Ratio of 11.02. This indicates that ALCOX is financially healthy and has no problem in meeting its short term obligations.
ALCOX has a Quick ratio of 11.02. This is amongst the best in the industry. ALCOX outperforms 93.98% of its industry peers.
Industry RankSector Rank
Current Ratio 11.02
Quick Ratio 11.02
ALCOX.PA Yearly Current Assets VS Current LiabilitesALCOX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.81% over the past year.
The Revenue has grown by 13.86% in the past year. This is quite good.
The Revenue has been growing slightly by 2.77% on average over the past years.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)13.86%
Revenue growth 3Y2.81%
Revenue growth 5Y2.77%
Sales Q2Q%-74.79%

3.2 Future

Based on estimates for the next years, ALCOX will show a very strong growth in Earnings Per Share. The EPS will grow by 54.92% on average per year.
Based on estimates for the next years, ALCOX will show a very strong growth in Revenue. The Revenue will grow by 102.03% on average per year.
EPS Next Y96%
EPS Next 2Y54.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCOX.PA Yearly Revenue VS EstimatesALCOX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALCOX.PA Yearly EPS VS EstimatesALCOX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCOX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 2.88, the valuation of ALCOX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than ALCOX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALCOX to the average of the S&P500 Index (23.56), we can say ALCOX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.88
ALCOX.PA Price Earnings VS Forward Price EarningsALCOX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCOX.PA Per share dataALCOX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALCOX's earnings are expected to grow with 54.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.92%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALCOX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NICOX SA

EPA:ALCOX (12/8/2025, 7:00:00 PM)

0.2965

-0.01 (-2.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-15 2025-10-15
Earnings (Next)04-28 2026-04-28/amc
Inst Owners4.51%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap24.09M
Revenue(TTM)3.32M
Net Income(TTM)-26.95M
Analysts84.44
Price Target1.53 (416.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-116.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-21.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.88
P/S 7.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.1
Fwd EY34.74%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -179.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.69%
ROA(5y)-42.4%
ROE(3y)-266.03%
ROE(5y)-174.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.02
Quick Ratio 11.02
Altman-Z -57.64
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y96%
EPS Next 2Y54.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.86%
Revenue growth 3Y2.81%
Revenue growth 5Y2.77%
Sales Q2Q%-74.79%
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOX SA / ALCOX.PA FAQ

What is the ChartMill fundamental rating of NICOX SA (ALCOX.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCOX.PA.


Can you provide the valuation status for NICOX SA?

ChartMill assigns a valuation rating of 4 / 10 to NICOX SA (ALCOX.PA). This can be considered as Fairly Valued.


How profitable is NICOX SA (ALCOX.PA) stock?

NICOX SA (ALCOX.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for NICOX SA (ALCOX.PA) stock?

The Earnings per Share (EPS) of NICOX SA (ALCOX.PA) is expected to grow by 96% in the next year.